GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: On September 6th, 2012, Meda announced an acquisition of pharmaceutical products within Women’s Health from Jazz Pharmaceuticals. This acquisition has now been completed. The purchase price was 95 MUSD. An experienced sales force of about 60 employees has also joined Meda. MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.
